GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pro-Dex Inc (FRA:PDXN) » Definitions » Cyclically Adjusted PS Ratio

Pro-Dex (FRA:PDXN) Cyclically Adjusted PS Ratio : 2.13 (As of Jun. 20, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Pro-Dex Cyclically Adjusted PS Ratio?

As of today (2024-06-20), Pro-Dex's current share price is €17.10. Pro-Dex's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €8.01. Pro-Dex's Cyclically Adjusted PS Ratio for today is 2.13.

The historical rank and industry rank for Pro-Dex's Cyclically Adjusted PS Ratio or its related term are showing as below:

FRA:PDXN' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.29   Med: 1.95   Max: 7.38
Current: 2.08

During the past years, Pro-Dex's highest Cyclically Adjusted PS Ratio was 7.38. The lowest was 0.29. And the median was 1.95.

FRA:PDXN's Cyclically Adjusted PS Ratio is ranked better than
50.1% of 479 companies
in the Medical Devices & Instruments industry
Industry Median: 2.12 vs FRA:PDXN: 2.08

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Pro-Dex's adjusted revenue per share data for the three months ended in Mar. 2024 was €3.732. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €8.01 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Pro-Dex Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Pro-Dex's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pro-Dex Cyclically Adjusted PS Ratio Chart

Pro-Dex Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.29 3.12 5.04 2.25 2.36

Pro-Dex Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.09 2.36 1.87 2.03 1.93

Competitive Comparison of Pro-Dex's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, Pro-Dex's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pro-Dex's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pro-Dex's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Pro-Dex's Cyclically Adjusted PS Ratio falls into.



Pro-Dex Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Pro-Dex's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=17.10/8.01
=2.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pro-Dex's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Pro-Dex's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=3.732/131.7762*131.7762
=3.732

Current CPI (Mar. 2024) = 131.7762.

Pro-Dex Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.600 100.560 0.786
201409 0.478 100.428 0.627
201412 0.543 99.070 0.722
201503 0.872 99.621 1.153
201506 0.877 100.684 1.148
201509 0.881 100.392 1.156
201512 1.153 99.792 1.523
201603 1.108 100.470 1.453
201606 1.061 101.688 1.375
201609 1.114 101.861 1.441
201612 1.065 101.863 1.378
201703 1.526 102.862 1.955
201706 1.228 103.349 1.566
201709 1.034 104.136 1.308
201712 1.068 104.011 1.353
201803 1.012 105.290 1.267
201806 1.219 106.317 1.511
201809 1.355 106.507 1.676
201812 1.326 105.998 1.648
201903 1.425 107.251 1.751
201906 1.483 108.070 1.808
201909 1.600 108.329 1.946
201912 1.768 108.420 2.149
202003 1.925 108.902 2.329
202006 2.410 108.767 2.920
202009 1.835 109.815 2.202
202012 1.693 109.897 2.030
202103 2.486 111.754 2.931
202106 2.088 114.631 2.400
202109 2.248 115.734 2.560
202112 2.390 117.630 2.677
202203 2.244 121.301 2.438
202206 3.199 125.017 3.372
202209 3.031 125.227 3.190
202212 2.916 125.222 3.069
202303 3.372 127.348 3.489
202306 2.743 128.729 2.808
202309 3.154 129.860 3.201
202312 3.196 129.419 3.254
202403 3.732 131.776 3.732

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Pro-Dex  (FRA:PDXN) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Pro-Dex Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Pro-Dex's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pro-Dex (FRA:PDXN) Business Description

Traded in Other Exchanges
Address
2361 McGaw Avenue, Irvine, CA, USA, 92614
Pro-Dex Inc is engaged in designing, developing, and manufacturing powered rotary drive surgical and dental instruments used primarily in the orthopedic, spine, maxocranial facial and dental markets. The company also designs and manufactures multi-axis motion control systems used in factory automation and scientific research markets. In addition, the company provides engineering consulting and placement services, as well as quality and regulatory consulting services. Most of the company's revenue is derived from designing, developing, and manufacturing surgical devices for the medical device and dental industries.

Pro-Dex (FRA:PDXN) Headlines

No Headlines